CRISPR Therapeutics to Present at the American Association

CRISPR Therapeutics to Present at the American Association

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating......

Kura Oncology Announces Acceptance of Two Abstracts for

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine kinase inhibitors – SAN DIEGO, March ......

Nurix Therapeutics Announces Presentations at the American

Nurix Therapeutics Announces Presentations at the American

Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948......

Sana Biotechnology Announces the Acceptance of Four

Sana Biotechnology Announces the Acceptance of Four

Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene......

Cullinan Oncology to Present New Preclinical Data for

Cullinan Oncology to Present New Preclinical Data for

CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with advanced solid tumors. Initial......

The Lovesac Company to Announce Fourth Quarter and Fiscal

The Lovesac Company to Announce Fourth Quarter and Fiscal

STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) today announced that its fourth quarter and fiscal 2023 financial......

Adamis Pharmaceuticals Schedules Fourth Quarter and Full

Adamis Pharmaceuticals Schedules Fourth Quarter and Full

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily......

Ed Mylett to Inspire and Motivate as Keynote Speaker at

Ed Mylett to Inspire and Motivate as Keynote Speaker at

Find your true path with Ed Mylett at eXp Shareholder Summit, May 17-20, 2023 in Orlando, FL......

LumiraDx to Announce Fourth Quarter and Full Year 2022

LumiraDx to Announce Fourth Quarter and Full Year 2022

LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will......

Repligen Corporation to Present at KeyBanc Life Science and

Repligen Corporation to Present at KeyBanc Life Science and

WALTHAM, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology......

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 44
  • menu
    menu